 |
TOKYO, Dec. 18, 2025 /PRNewswire/ — Nabsys 2.0, LLC (Nabsys), a pioneer in digital genome mapping know-how, in partnership with Hitachi Excessive-Tech Company (HHT) proclaims the presentation of excessive decision structural variation knowledge on the OhmX(™) platform on the Japanese Society of Human Genetics (JSHG) Annual Assembly going down on December 17-20, 2025, in Yokohama, Japan.
In partnership with Dr. Catherine Brownstein, M.P.H., Ph.D. from Boston Youngsters’s Hospital, Nabsys and HHT will host a luncheon seminar on Thursday, December 18, 2025 from 12:25-1:25 PM on the Yokohama Convention Middle (3F, Room 304). Attendees will hear about developments in structural variant evaluation with digital genome mapping (EGM) from audio system Dr. Tadashi Kaname from the Division of Genome Medication Analysis, Nationwide Middle for Well being and Improvement, Edd Lee, International Vice President of Gross sales and Advertising and marketing, Nabsys, and Dr. Catherine Brownstein, Scientific Director, Manton Middle Gene Discovery Core; Analysis Affiliate, Division of Genetics and Genomics; Assistant Director, Molecular Genetics Core; and Assistant Professor, Harvard Medical College.
The information offered show the usage of EGM know-how at a tertiary kids’s hospital and analysis middle, and the way the OhmX Platform works in symphony with a complete multi-omics technique to speed up uncommon illness gene discovery.
Dr. Brownstein, M.P.H., Ph.D., Boston Youngsters’s Hospital remarked, “Nabsys’ EGM know-how, which delivers excessive decision evaluation of genome-wide structural variation, enabled us with insights into beforehand undetectable structural variation and has thus develop into an important device to know underlying illness etiology of notably uncommon or difficult-to-diagnose illnesses. The information demonstrates the significance of Nabsys’ groundbreaking know-how for understanding difficult biomarkers and accelerating analysis in a hospital setting.”
Along with the hosted luncheon, Nabsys and Hitachi Excessive-Tech America, Inc. (HTA) will current a scientific poster on “Excessive Decision Detection of TP53 Deletions utilizing Digital Genome Mapping” describing the efficacy of EGM when utilized to most cancers genomics.
Title: Excessive-Decision Detection of TP53 Deletions utilizing Digital Genome Mapping
Presenter: Shuk Shukor, Hitachi Excessive-Tech America, Inc.
Summary Quantity: P3-02-14
Session: Poster Session 3-02 “Most cancers Genetics 3”
Date/Time: December 20, 2025, 14:20-15:20 (JST)
“We’re happy to current a breadth of recent and essential analysis at this yr’s JSHG assembly that elucidates the real-world impression our product, the OhmX Platform, is having on researchers,” mentioned Barrett Bready, M.D., founder and CEO of Nabsys. “The luncheon seminar and our analysis communicate to the significance of velocity, accessibility, and accuracy in researching whole-genome structural variations, and we’re proud to share further knowledge that show how our platform has revolutionized genome mapping.”
About Nabsys 2.0, LLC
Nabsys is advancing genomics with a transparent give attention to accessibility and innovation by way of its proprietary digital genome mapping (EGM) know-how. Carried out on the OhmX Platform™, EGM integrates precision electronics, nanofluidics, and computational biology to ship high-resolution perception into genome construction. This method expands what’s doable in cytogenetics, molecular genetics, and cell and gene remedy analysis, whereas offering complete structural variation evaluation to laboratories of all sizes. The corporate was based in 2005 and is predicated in Windfall, Rhode Island. For extra info, go to www.nabsys.com.
About Hitachi Excessive-Tech Company
Hitachi Excessive-Tech supplies cutting-edge applied sciences, services and products to society and prospects with its company imaginative and prescient of “Altering the World and Future with the Energy of Information” to contribute to a sustainable international surroundings, wholesome, secure, and safe lives, and the sustained growth of science and trade. We manufacture and promote medical analyzers, biotechnology merchandise, and radiation remedy techniques within the healthcare subject, semiconductor manufacturing and inspection gear within the semiconductor subject, in addition to analytical techniques and electron microscopes utilized in environmental fields and supplies analysis. We’re additionally engaged in a variety of enterprise areas globally, offering excessive added-value options in battery, communication infrastructure, railway inspection, digital, and different industrial and social infrastructure fields. By deeply understanding the problems dealing with society and our prospects and using the put in base (Digitalized Belongings) and area information, we offer digital providers by way of Lumada 3.0, enhanced by AI. Together with the Encourage 2027, Hitachi Group’s New Administration plan, we contribute to comprehend a harmonized society the place the surroundings, wellbeing, and financial development coexist in concord. The corporate’s consolidated revenues for FY2024 had been approx. JPY 756.5 billion.
For additional info, go to https://www.hitachi-hightech.com/international/en/
Media Contact
David Rosen
Argot Companions
David.rosen@argotpartners.com
646-461-6387
Brand – https://laotiantimes.com/wp-content/uploads/2025/12/nabsys_logo.jpg
